Cargando…
The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial
OBJECTIVE: Intrathecal baclofen treatment is used for the treatment of dystonia in patients with severe dyskinetic cerebral palsy; however, the current level of evidence for the effect is low. The primary aim of this study was to provide evidence for the effect of intrathecal baclofen treatment on i...
Autores principales: | Bonouvrié, Laura A., Becher, Jules G., Vles, Johan S. H., Vermeulen, R. Jeroen, Buizer, Annemieke I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617761/ https://www.ncbi.nlm.nih.gov/pubmed/31050023 http://dx.doi.org/10.1002/ana.25498 |
Ejemplares similares
-
Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial
por: Bonouvrié, Laura A, et al.
Publicado: (2013) -
Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
por: Haberfehlner, Helga, et al.
Publicado: (2019) -
Instrumented assessment of motor function in dyskinetic cerebral palsy: a systematic review
por: Haberfehlner, Helga, et al.
Publicado: (2020) -
Effect of continuous intrathecal baclofen therapy in children: a systematic review
por: Buizer, Annemieke I, et al.
Publicado: (2018) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018)